Veon (VEON) EBITDA (2009 - 2026)

Veon (VEON) has reported EBITDA for 17 consecutive years, with $58.6 billion the latest figure, recorded in Q1 2026.

• EBITDA for Q1 2026 came in at $58.6 billion, up 29.37% year-over-year; the trailing twelve-month figure through Mar 2026 was $104.7 billion (up 129.15% YoY), and the FY2025 annual result was $2.0 billion, up 23.06% from the prior year.
• EBITDA was $58.6 billion for Q1 2026 at Veon, up from $678.0 million in the prior quarter.
• Over five years, EBITDA peaked at $58.6 billion in Q1 2026 and troughed at $80.0 million in Q2 2022.
• Average EBITDA over 5 years is $13.2 billion, with a median of $158.5 million recorded in 2022.
• Year-over-year, EBITDA surged 544.74% in 2022 and rose 29.37% in 2026.
• Over 5 years, EBITDA stood at $169.0 million in 2022, then sank by 35.5% to $109.0 million in 2023, then jumped by 35.78% to $148.0 million in 2024, then soared by 358.11% to $678.0 million in 2025, then jumped by 8541.59% to $58.6 billion in 2026.
• Per Business Quant data, the three most recent EBITDA figures were $58.6 billion in Q1 2026, $678.0 million in Q2 2025, and $45.3 billion in Q1 2025.